{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:25:25Z","timestamp":1782825925454,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,21]]},"DOI":"10.7759\/cureus.62821","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:30:54Z","timestamp":1718969454000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical Outcomes Following SARS-CoV-2 Infection in Pediatric Cystic Fibrosis Patients"],"prefix":"10.7759","author":[{"given":"Andy P","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Espina Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie  G","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floyd R","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe SM","year":"2005","unstructured":"Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005, 352:1992-2001. 10.1056\/NEJMra043184","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90155-6","article-title":"Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)","volume":"68","author":"Bear CE","year":"1992","unstructured":"Bear CE, Li CH, Kartner N, et al.. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell J. 1992, 68:809-18. 10.1016\/0092-8674(92)90155-6","journal-title":"Cell J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0929-693x(20)30044-0","article-title":"CFTR gene variants, epidemiology and molecular pathology","volume":"27","author":"Bareil C","year":"2020","unstructured":"Bareil C, Bergougnoux A. CFTR gene variants, epidemiology and molecular pathology. Arch Pediatr. 2020, 27:8-12. 10.1016\/s0929-693x(20)30044-0","journal-title":"Arch Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1891\/NN-2022-0007","article-title":"Cystic fibrosis: back to the basics","volume":"42","author":"Myer H","year":"2023","unstructured":"Myer H, Chupita S, Jnah A. Cystic fibrosis: back to the basics. Neonatal Netw. 2023, 42:23-30. 10.1891\/NN-2022-0007","journal-title":"Neonatal Netw"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ng1192-240","article-title":"Submucosal glands are the predominant site of CFTR expression in the human bronchus","volume":"2","author":"Engelhardt JF","year":"1992","unstructured":"Engelhardt JF, Yankaskas JR, Ernst SA, et al.. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet. 1992, 2:240-8. 10.1038\/ng1192-240","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2019-0212","article-title":"Cystic fibrosis","volume":"42","author":"Dickinson KM","year":"2021","unstructured":"Dickinson KM, Collaco JM. Cystic fibrosis. Pediatr Rev. 2021, 42:55-67. 10.1542\/pir.2019-0212","journal-title":"Pediatr Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-022-01108-8","article-title":"A comprehensive SARS-CoV-2 and COVID-19 review, part 1: Intracellular overdrive for SARS-CoV-2 infection","volume":"30","author":"Jamison DA Jr","year":"2022","unstructured":"Jamison DA Jr, Anand Narayanan S, Trov\u00e3o NS, et al.. A comprehensive SARS-CoV-2 and COVID-19 review, part 1: Intracellular overdrive for SARS-CoV-2 infection. Eur J Hum Genet. 2022, 30:889-98. 10.1038\/s41431-022-01108-8","journal-title":"Eur J Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong E","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020, 20:533-4. 10.1016\/S1473-3099(20)30120-1","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100522","article-title":"System-wide transcriptome damage and tissue identity loss in COVID-19 patients","volume":"3","author":"Park J","year":"2022","unstructured":"Park J, Foox J, Hether T, et al.. System-wide transcriptome damage and tissue identity loss in COVID-19 patients. Cell Rep Med. 2022, 3:100522. 10.1016\/j.xcrm.2022.100522","journal-title":"Cell Rep Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang D","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al.. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020, 323:1061-9. 10.1001\/jama.2020.1585","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50698","article-title":"Clinical presentation and management of COVID-19","volume":"213","author":"Thevarajan I","year":"2020","unstructured":"Thevarajan I, Buising KL, Cowie BC. Clinical presentation and management of COVID-19. Med J Aust. 2020, 213:134-9. 10.5694\/mja2.50698","journal-title":"Med J Aust"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-0999LE","article-title":"Improved prognosis in cystic fibrosis: consideration for intensive care during the COVID-19 pandemic","volume":"201","author":"Ramos KJ","year":"2020","unstructured":"Ramos KJ, Pilewski JM, Faro A, Marshall BC. Improved prognosis in cystic fibrosis: consideration for intensive care during the COVID-19 pandemic. Am J Respir Crit Care Med. 2020, 201:1434-5. 10.1164\/rccm.202004-0999LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(03)00114-6","article-title":"Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis","volume":"18","author":"Zheng S","year":"2003","unstructured":"Zheng S, De BP, Choudhary S, et al.. Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis. Immunity. 2003, 18:619-30. 10.1016\/s1074-7613(03)00114-6","journal-title":"Immunity"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199812)26:6<371::AID-PPUL1>3.0.CO;2-N","article-title":"Severe viral respiratory infections in infants with cystic fibrosis","volume":"26","author":"Armstrong D","year":"1998","unstructured":"Armstrong D, Grimwood K, Carlin JB, Carzino R, Hull J, Olinsky A, Phelan P. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol. 1998, 26:371-9. 10.1002\/(SICI)1099-0496(199812)26:6&lt;371::AID-PPUL1&gt;3.0.CO;2-N","journal-title":"Pediatr Pulmonol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/adc.73.2.117","article-title":"Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis","volume":"73","author":"Smyth AR","year":"1995","unstructured":"Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child. 1995, 73:117-20. 10.1136\/adc.73.2.117","journal-title":"Arch Dis Child"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1136\/thx.51.11.1115","article-title":"Effects of upper respiratory tract infections in patients with cystic fibrosis","volume":"51","author":"Collinson J","year":"1996","unstructured":"Collinson J, Nicholson KG, Cancio E, et al.. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax. 1996, 51:1115-22.","journal-title":"Thorax"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106606","article-title":"Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: a multicenter retrospective research network study","volume":"188","author":"Hadi YB","year":"2021","unstructured":"Hadi YB, Lakhani DA, Naqvi SF, Fatima NU, Sarwari AR. Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: a multicenter retrospective research network study. Respir Med. 2021, 188:106606. 10.1016\/j.rmed.2021.106606","journal-title":"Respir Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson JL","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999, 159:179-87. 10.1164\/ajrccm.159.1.9712108","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.958658","article-title":"Risk factors for severe COVID-19 in people with cystic fibrosis: a systematic review","volume":"10","author":"Terlizzi V","year":"2022","unstructured":"Terlizzi V, Motisi MA, Pellegrino R, Padoan R, Chiappini E. Risk factors for severe COVID-19 in people with cystic fibrosis: a systematic review. Front Pediatr. 2022, 10:958658. 10.3389\/fped.2022.958658","journal-title":"Front Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00411-2021","article-title":"Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe","volume":"7","author":"Jung A","year":"2021","unstructured":"Jung A, Orenti A, Dunlevy F, et al.. Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe. ERJ Open Res. 2021, 7:10.1183\/23120541.00411-2021","journal-title":"ERJ Open Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35862-0","article-title":"SARS-CoV-2 viral entry and replication is impaired in cystic fibrosis airways due to ACE2 downregulation","volume":"14","author":"Bezzerri V","year":"2023","unstructured":"Bezzerri V, Gentili V, Api M, et al.. SARS-CoV-2 viral entry and replication is impaired in cystic fibrosis airways due to ACE2 downregulation. Nat Commun. 2023, 14:132. 10.1038\/s41467-023-35862-0","journal-title":"Nat Commun"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-021-09771-0","article-title":"Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2","volume":"17","author":"Abraham EH","year":"2021","unstructured":"Abraham EH, Guidotti G, Rapaport E, et al.. Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2. Purinergic Signal. 2021, 17:399-410. 10.1007\/s11302-021-09771-0","journal-title":"Purinergic Signal"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.11.021","article-title":"Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study","volume":"20","author":"Bain R","year":"2021","unstructured":"Bain R, Cosgriff R, Zampoli M, et al.. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study. J Cyst Fibros. 2021, 20:25-30. 10.1016\/j.jcf.2020.11.021","journal-title":"J Cyst Fibros"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42:377-81. 10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019, 95:103208. 10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3758\/bf03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul F","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007, 39:175-91. 10.3758\/bf03193146","journal-title":"Behav Res Methods"},{"key":"ref27","article-title":"2021 Patient Registry Annual Data Report","year":"2021","unstructured":"2021 Patient Registry Annual Data Report. Cystic Fibrosis Foundation, Bethesda, MD; 2021."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/221946-clinical-outcomes-following-sars-cov-2-infection-in-pediatric-cystic-fibrosis-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:31:02Z","timestamp":1718969462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/221946-clinical-outcomes-following-sars-cov-2-infection-in-pediatric-cystic-fibrosis-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.62821","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}